Skip to content

GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care

GUT LINK: A Pilot Study to Evaluate the Comparative Effectiveness of an Evidence-based Care Pathway Across Primary and GI Specialty Care

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05725954
Enrollment
0
Registered
2023-02-13
Start date
2024-02-01
Completion date
2028-12-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GI Disorders, Irritable Bowel Syndrome

Keywords

Care pathway, Care delivery, virtual

Brief summary

It can be challenging for Primary Healthcare Providers (PHCPs) to differentiate between IBS and more serious illnesses involving the GI tract, such as Crohn's disease, ulcerative colitis, or cancer. To help with diagnosis and treatment of IBS, evidence-based guidelines have been developed. However, they are not commonly used in primary care practice and PHCPs and patients often feel that GI specialist evaluation and endoscopy is required. The development of care pathways and clinical practice guidelines is essential to support the investigation and management of digestive diseases, such as IBS. The current pilot study is designed to assess the implementation and early comparative effectiveness of a Clinical Care Pathway for lower GI tract symptoms.

Interventions

BEHAVIORALGUT LINK SmartPath

A virtual care delivery and referral support tool for primary healthcare providers.

Sponsors

Michael Stewart
Lead SponsorOTHER
Nova Scotia Health Authority
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Must be a general practitioner * Have a family practice in Nova Scotia, Canada * Utilize the platform 'virtual hallway' as part of current referral practices * Deliver care to patients with lower GI complaints

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Number of usersmonth 3Number of users (an indicator of prototype acceptability)
Number of referralsmonth 3Number of referrals from GPs to GI Department (an indicator of prototype acceptability)
Number of referrals per weekmonth 3Number of referrals per week from GPs to GI Department (an indicator of prototype acceptability)
Number of referrals per usermonth 3Number of referrals per week from GPs to GI Department (an indicator of prototype acceptability)
Number of clicks per referralmonth 3Number of clicks per referral from GPs to GI Department (an indicator of prototype acceptability)
Primary Healthcare Provider Satisfactionbaseline (month 0)Thematic analysis of interviews of primary care providers will yield key themes related to satisfaction with the intervention.

Secondary

MeasureTime frameDescription
Number referrals received as per prototypemonth 3Number referrals received as per prototype (an implementation metric)
Number of referrals received requiring troubleshootingmonth 3Number of referrals received requiring troubleshooting (an implementation metric)
Number of referrals abortedmonth 3Number of referrals aborted (an implementation metric)
Type of consultmonth 3Type of consult (Full consult, specialist telephone advice, eConsult)
Perceived appropriateness of the SmartPathmonth 3Thematic analysis of interviews of primary care providers will yield key themes related to the perceived appropriateness of the intervention
physician self-efficacy ratingmonth 3physician self-efficacy rating, measured using the 'New General Self Efficacy Scale' (an effectiveness metric of GUT LINK Smartpath). Min score: 1, max score: 8. A higher score indicates a greater self-efficacy.
Referral triage priority categorymonth 3Referral triage priority category will be collected from referrals through the pathway (an effectiveness metric of GUT LINK Smartpath). Referral triage categories to the GI department are: emergent, semi urgent, and non-urgent.
Time from referral to specialist consultationmonth 3Time from referral to specialist consultation, in weeks (an effectiveness metric of GUT LINK Smartpath)
Time from referral to diagnosis and treatmentmonth 3Time from referral to diagnosis and treatment, in weeks (an effectiveness metric of GUT LINK Smartpath)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026